Clinical Trial Update: Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rituximab plus mycophenolate mofetil without oral steroids for lupus nephritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Rituximab (rituximab)

Snippet

Sponsor: Imperial College London | Conditions: Systemic Lupus Erythematosus, Lupus Nephritis | Phase 3 | Status: TERMINATED